Insulin resistance: A significant risk factor of endometrial cancer
2012 · Gynecologic Oncology · 176 citations
https://doi.org/10.1016/j.ygyno.2012.03.032
N
Nan Mu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
2.1K
Citations
28
h-index
45
i10-index
Nan Mu is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Metabolism, Diabetes, and Cancer & Diabetes Treatment and Management & Endometrial and Cervical Cancer Treatments. The author has an h-index of 28, co-authored 69 publications.
ORCID: 0000-0002-3494-8145Papers by this author
worksMiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1
2018 · Experimental Cell Research · 93 citations
https://doi.org/10.1016/j.yexcr.2018.12.016
Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases
2023 · Journal of Translational Medicine · 53 citations
https://doi.org/10.1186/s12967-023-04203-6
Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line
2017 · Cancer Cell International · 42 citations
https://doi.org/10.1186/s12935-017-0459-x
DDR2–CYR61–MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes
2016 · Journal of Bone and Mineral Research · 31 citations
https://doi.org/10.1002/jbmr.2993
Expression, purification and characterization of galectin-1 in Escherichia coli
2014 · Protein Expression and Purification · 12 citations
https://doi.org/10.1016/j.pep.2014.03.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat